Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
Aims To explore whether there is a different strength of association between self‐rated health and all‐cause mortality in people with type 2 diabetes across three country groupings: nine countries grouped together as 'established market economies'; Asia; and Eastern Europe. Methods The ADV...
Uloženo v:
| Vydáno v: | Diabetic medicine Ročník 37; číslo 8; s. 1379 - 1385 |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Wiley Subscription Services, Inc
01.08.2020
John Wiley and Sons Inc |
| Témata: | |
| ISSN: | 0742-3071, 1464-5491, 1464-5491 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Aims
To explore whether there is a different strength of association between self‐rated health and all‐cause mortality in people with type 2 diabetes across three country groupings: nine countries grouped together as 'established market economies'; Asia; and Eastern Europe.
Methods
The ADVANCE trial and its post‐trial follow‐up were used in this study, which included 11 140 people with type 2 diabetes from 20 countries, with a median follow‐up of 9.9 years. Self‐rated health was reported on a 0–100 visual analogue scale. Cox proportional hazard models were fitted to estimate the relationship between the visual analogue scale score and all‐cause mortality, controlling for a range of demographic and clinical risk factors. Interaction terms were used to assess whether the association between the visual analogue scale score and mortality varied across country groupings.
Results
The visual analogue scale score had different strengths of association with mortality in the three country groupings. A 10‐point increase in visual analogue scale score was associated with a 15% (95% CI 12–18) lower mortality hazard in the established market economies, a 25% (95% CI 21–28) lower hazard in Asia, and an 8% (95% CI 3–13) lower hazard in Eastern Europe.
Conclusions
Self‐rated health appears to predict 10‐year all‐cause mortality for people with type 2 diabetes worldwide, but this relationship varies across groups of countries.
What's new?
Self‐rated health is an independent predictor of mortality in people with diabetes.
The visual analogue scale (VAS) score has a stronger association with mortality in Asia and a weaker association in Eastern Europe than in the 'established market economies' included in our study among people with type 2 diabetes.
People with type 2 diabetes in different countries reporting the same VAS score can face different mortality risks.
The VAS score can be a useful global health measure in clinical practice for people with type 2 diabetes, but adjustment would be required before it can be directly compared across countries and regions. |
|---|---|
| AbstractList | Self‐rated health is an independent predictor of mortality in people with diabetes.The visual analogue scale (VAS) score has a stronger association with mortality in Asia and a weaker association in Eastern Europe than in the 'established market economies' included in our study among people with type 2 diabetes.People with type 2 diabetes in different countries reporting the same VAS score can face different mortality risks.The VAS score can be a useful global health measure in clinical practice for people with type 2 diabetes, but adjustment would be required before it can be directly compared across countries and regions. To explore whether there is a different strength of association between self-rated health and all-cause mortality in people with type 2 diabetes across three country groupings: nine countries grouped together as 'established market economies'; Asia; and Eastern Europe. The ADVANCE trial and its post-trial follow-up were used in this study, which included 11 140 people with type 2 diabetes from 20 countries, with a median follow-up of 9.9 years. Self-rated health was reported on a 0-100 visual analogue scale. Cox proportional hazard models were fitted to estimate the relationship between the visual analogue scale score and all-cause mortality, controlling for a range of demographic and clinical risk factors. Interaction terms were used to assess whether the association between the visual analogue scale score and mortality varied across country groupings. The visual analogue scale score had different strengths of association with mortality in the three country groupings. A 10-point increase in visual analogue scale score was associated with a 15% (95% CI 12-18) lower mortality hazard in the established market economies, a 25% (95% CI 21-28) lower hazard in Asia, and an 8% (95% CI 3-13) lower hazard in Eastern Europe. Self-rated health appears to predict 10-year all-cause mortality for people with type 2 diabetes worldwide, but this relationship varies across groups of countries. AimsTo explore whether there is a different strength of association between self‐rated health and all‐cause mortality in people with type 2 diabetes across three country groupings: nine countries grouped together as 'established market economies'; Asia; and Eastern Europe.MethodsThe ADVANCE trial and its post‐trial follow‐up were used in this study, which included 11 140 people with type 2 diabetes from 20 countries, with a median follow‐up of 9.9 years. Self‐rated health was reported on a 0–100 visual analogue scale. Cox proportional hazard models were fitted to estimate the relationship between the visual analogue scale score and all‐cause mortality, controlling for a range of demographic and clinical risk factors. Interaction terms were used to assess whether the association between the visual analogue scale score and mortality varied across country groupings.ResultsThe visual analogue scale score had different strengths of association with mortality in the three country groupings. A 10‐point increase in visual analogue scale score was associated with a 15% (95% CI 12–18) lower mortality hazard in the established market economies, a 25% (95% CI 21–28) lower hazard in Asia, and an 8% (95% CI 3–13) lower hazard in Eastern Europe.ConclusionsSelf‐rated health appears to predict 10‐year all‐cause mortality for people with type 2 diabetes worldwide, but this relationship varies across groups of countries. Aims To explore whether there is a different strength of association between self‐rated health and all‐cause mortality in people with type 2 diabetes across three country groupings: nine countries grouped together as 'established market economies'; Asia; and Eastern Europe. Methods The ADVANCE trial and its post‐trial follow‐up were used in this study, which included 11 140 people with type 2 diabetes from 20 countries, with a median follow‐up of 9.9 years. Self‐rated health was reported on a 0–100 visual analogue scale. Cox proportional hazard models were fitted to estimate the relationship between the visual analogue scale score and all‐cause mortality, controlling for a range of demographic and clinical risk factors. Interaction terms were used to assess whether the association between the visual analogue scale score and mortality varied across country groupings. Results The visual analogue scale score had different strengths of association with mortality in the three country groupings. A 10‐point increase in visual analogue scale score was associated with a 15% (95% CI 12–18) lower mortality hazard in the established market economies, a 25% (95% CI 21–28) lower hazard in Asia, and an 8% (95% CI 3–13) lower hazard in Eastern Europe. Conclusions Self‐rated health appears to predict 10‐year all‐cause mortality for people with type 2 diabetes worldwide, but this relationship varies across groups of countries. What's new? Self‐rated health is an independent predictor of mortality in people with diabetes. The visual analogue scale (VAS) score has a stronger association with mortality in Asia and a weaker association in Eastern Europe than in the 'established market economies' included in our study among people with type 2 diabetes. People with type 2 diabetes in different countries reporting the same VAS score can face different mortality risks. The VAS score can be a useful global health measure in clinical practice for people with type 2 diabetes, but adjustment would be required before it can be directly compared across countries and regions. Self‐rated health is an independent predictor of mortality in people with diabetes. The visual analogue scale (VAS) score has a stronger association with mortality in Asia and a weaker association in Eastern Europe than in the 'established market economies' included in our study among people with type 2 diabetes. People with type 2 diabetes in different countries reporting the same VAS score can face different mortality risks. The VAS score can be a useful global health measure in clinical practice for people with type 2 diabetes, but adjustment would be required before it can be directly compared across countries and regions. To explore whether there is a different strength of association between self-rated health and all-cause mortality in people with type 2 diabetes across three country groupings: nine countries grouped together as 'established market economies'; Asia; and Eastern Europe.AIMSTo explore whether there is a different strength of association between self-rated health and all-cause mortality in people with type 2 diabetes across three country groupings: nine countries grouped together as 'established market economies'; Asia; and Eastern Europe.The ADVANCE trial and its post-trial follow-up were used in this study, which included 11 140 people with type 2 diabetes from 20 countries, with a median follow-up of 9.9 years. Self-rated health was reported on a 0-100 visual analogue scale. Cox proportional hazard models were fitted to estimate the relationship between the visual analogue scale score and all-cause mortality, controlling for a range of demographic and clinical risk factors. Interaction terms were used to assess whether the association between the visual analogue scale score and mortality varied across country groupings.METHODSThe ADVANCE trial and its post-trial follow-up were used in this study, which included 11 140 people with type 2 diabetes from 20 countries, with a median follow-up of 9.9 years. Self-rated health was reported on a 0-100 visual analogue scale. Cox proportional hazard models were fitted to estimate the relationship between the visual analogue scale score and all-cause mortality, controlling for a range of demographic and clinical risk factors. Interaction terms were used to assess whether the association between the visual analogue scale score and mortality varied across country groupings.The visual analogue scale score had different strengths of association with mortality in the three country groupings. A 10-point increase in visual analogue scale score was associated with a 15% (95% CI 12-18) lower mortality hazard in the established market economies, a 25% (95% CI 21-28) lower hazard in Asia, and an 8% (95% CI 3-13) lower hazard in Eastern Europe.RESULTSThe visual analogue scale score had different strengths of association with mortality in the three country groupings. A 10-point increase in visual analogue scale score was associated with a 15% (95% CI 12-18) lower mortality hazard in the established market economies, a 25% (95% CI 21-28) lower hazard in Asia, and an 8% (95% CI 3-13) lower hazard in Eastern Europe.Self-rated health appears to predict 10-year all-cause mortality for people with type 2 diabetes worldwide, but this relationship varies across groups of countries.CONCLUSIONSSelf-rated health appears to predict 10-year all-cause mortality for people with type 2 diabetes worldwide, but this relationship varies across groups of countries. |
| Author | Chalmers, J. Poulter, N. Clarke, P. M. Salomon, J. A. Mancia, G. Woodward, M. Hamet, P. Hua, X. Harrap, S. B. Lung, T. W. C. |
| AuthorAffiliation | 3 George Institute for Global Health UNSW Sydney Sydney NSW Australia 4 School of Public Health Faculty of Medicine and Health University of Sydney Sydney NSW Australia 7 Department of Medicine Stanford Medical School Stanford CA USA 5 George Institute for Global Health University of Oxford Oxford UK 8 Centre de Recherche Centre Hospitalier de l'Université de Montréal Montréal QC Canada 12 Imperial Clinical Trials Unit School of Public Health Imperial College London London UK 11 University of Milano‐Bicocca Milan Italy 9 Department of Medicine University of Montréal Montréal QC Canada 2 Nuffield Department of Population Health University of Oxford Oxford UK 10 Department of Physiology University of Melbourne Melbourne VIC Australia 6 Department of Epidemiology Johns Hopkins University Baltimore MD USA 1 School of Population and Global Health University of Melbourne Melbourne VIC Australia |
| AuthorAffiliation_xml | – name: 1 School of Population and Global Health University of Melbourne Melbourne VIC Australia – name: 10 Department of Physiology University of Melbourne Melbourne VIC Australia – name: 8 Centre de Recherche Centre Hospitalier de l'Université de Montréal Montréal QC Canada – name: 3 George Institute for Global Health UNSW Sydney Sydney NSW Australia – name: 11 University of Milano‐Bicocca Milan Italy – name: 12 Imperial Clinical Trials Unit School of Public Health Imperial College London London UK – name: 6 Department of Epidemiology Johns Hopkins University Baltimore MD USA – name: 7 Department of Medicine Stanford Medical School Stanford CA USA – name: 2 Nuffield Department of Population Health University of Oxford Oxford UK – name: 5 George Institute for Global Health University of Oxford Oxford UK – name: 4 School of Public Health Faculty of Medicine and Health University of Sydney Sydney NSW Australia – name: 9 Department of Medicine University of Montréal Montréal QC Canada |
| Author_xml | – sequence: 1 givenname: X. orcidid: 0000-0003-2102-5461 surname: Hua fullname: Hua, X. organization: University of Oxford – sequence: 2 givenname: T. W. C. surname: Lung fullname: Lung, T. W. C. organization: University of Sydney – sequence: 3 givenname: M. surname: Woodward fullname: Woodward, M. organization: Johns Hopkins University – sequence: 4 givenname: J. A. surname: Salomon fullname: Salomon, J. A. organization: Stanford Medical School – sequence: 5 givenname: P. surname: Hamet fullname: Hamet, P. organization: University of Montréal – sequence: 6 givenname: S. B. surname: Harrap fullname: Harrap, S. B. organization: University of Melbourne – sequence: 7 givenname: G. surname: Mancia fullname: Mancia, G. organization: University of Milano‐Bicocca – sequence: 8 givenname: N. surname: Poulter fullname: Poulter, N. organization: Imperial College London – sequence: 9 givenname: J. surname: Chalmers fullname: Chalmers, J. organization: UNSW Sydney – sequence: 10 givenname: P. M. orcidid: 0000-0002-7555-5348 surname: Clarke fullname: Clarke, P. M. email: philip.clarke@ndph.ox.ac.uk organization: University of Oxford |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31967344$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kstuEzEUhkeoiF5gwQsgS2xgkXY8tmfGLJCiNFyk0i64bC1nfJy48tiD7aHKjkfgaXggngSnSbhU4M2xfL7_12_7HBcHzjsoise4PMV5nakeTjGtSHOvOMK0phNGOT4ojsqGVhNSNviwOI7xuixxxQl_UBwSzOuGUHpUfH8PVv_4-i3IBAqtQNq0QrHzASIaAijTJdT7kKQ1aY1k790SDeAHC-jGZDStB0AVUkYuIGWNMlpDAJdsprvgY0RpFQB-N1DnR5fCGi2DHwfjlvEF0sapzQ7p4PssADQ9_zS9nM2RdGq_zymvLlEKRtr4sLivc4FHu3pSfHw1_zB7M7m4ev12Nr2YdJSSZiJrSjFWkgGnQHUrO93VTLYVq9VioXnbQD5kEquWLQhWQBRWjJWqkgxrzslJ8XLrO4yLHlSX8wdpxRBML8NaeGnE3x1nVmLpv4iG8pq3bTZ4tjMI_vMIMYnexA6slQ78GEVFKGFlyVqc0ad30Gs_BpevJypa0ZpQXtWZevJnol9R9l-agbMtcPv6AbToTJLJ-E1AYwUuxWZoRB4acTs0WfH8jmJv-i92535jLKz_D4rzd_Ot4ifUa9Y3 |
| CitedBy_id | crossref_primary_10_2147_DMSO_S528159 crossref_primary_10_1111_1753_0407_13522 crossref_primary_10_37527_2022_72_2_002 crossref_primary_10_1016_j_jval_2022_01_017 crossref_primary_10_1177_21582440241271292 crossref_primary_10_1016_j_socscimed_2023_116426 crossref_primary_10_1111_dme_14825 crossref_primary_10_1111_1753_0407_13294 crossref_primary_10_3389_fnut_2022_1051637 |
| Cites_doi | 10.1016/j.pcd.2009.01.001 10.1136/bmj.316.7133.736 10.2337/dc11-0755 10.1016/j.jclinepi.2005.12.004 10.4103/2229-3485.86879 10.1016/S0140-6736(09)61400-8 10.1136/hrt.2005.085381 10.2337/diacare.3.5.599 10.1093/aje/kwr290 10.1097/FJC.0b013e3181d26469 10.1093/her/cyf044 10.1002/hec.1134 10.1056/NEJMoa1407963 10.1161/CIR.0b013e3182949a2e 10.1161/JAHA.116.003741 10.1016/j.socscimed.2009.05.013 10.1136/bmjopen-2011-000760 10.1097/MLR.0b013e3181844855 10.2307/2955359 10.1016/S0140-6736(02)07466-4 10.1016/j.ahj.2015.12.009 10.2105/AJPH.91.1.99 10.1007/s10433-005-0032-7 10.1007/s11136-010-9762-x 10.1097/01.psy.0000188434.52941.a0 10.3109/07853890109002087 10.1097/MLR.0b013e3182239489 10.2337/dc07-1391 10.1016/j.jval.2015.10.010 |
| ContentType | Journal Article |
| Copyright | 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. 2020. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK – notice: 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. – notice: 2020. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION NPM 7T5 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
| DOI | 10.1111/dme.14237 |
| DatabaseName | Wiley Online Library Open Access CrossRef PubMed Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Genetics Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | PubMed Genetics Abstracts CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Nursing |
| DocumentTitleAlternate | Association between self‐rated health and mortality across countries |
| EISSN | 1464-5491 |
| EndPage | 1385 |
| ExternalDocumentID | PMC7496988 31967344 10_1111_dme_14237 DME14237 |
| Genre | article Journal Article |
| GeographicLocations | Eastern Europe Asia |
| GeographicLocations_xml | – name: Eastern Europe – name: Asia |
| GrantInformation_xml | – fundername: Australian Research Council funderid: CE170100005 – fundername: Health Research Biomedical Research Centre at the University of Oxford funderid: NIHR‐BRC‐1215‐20008 – fundername: National Health and Medical Research Council funderid: 1084347; 1141392; 1080206; 1079621 – fundername: National Health and Medical Research Council grantid: 1141392 – fundername: National Health and Medical Research Council grantid: 1079621 – fundername: Australian Research Council grantid: CE170100005 – fundername: Health Research Biomedical Research Centre at the University of Oxford grantid: NIHR-BRC-1215-20008 – fundername: National Health and Medical Research Council grantid: 1080206 – fundername: National Health and Medical Research Council grantid: 1084347 – fundername: ; grantid: CE170100005 – fundername: Health Research Biomedical Research Centre at the University of Oxford grantid: NIHR‐BRC‐1215‐20008 – fundername: ; grantid: 1084347; 1141392; 1080206; 1079621 |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 24P 29F 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RWI RX1 SAMSI SUPJJ TEORI UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 XV2 YFH YUY ZGI ZXP ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY CITATION O8X NPM 7T5 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c4437-a64411da5e94e4f8acfc65a8256dbbf987ef8a5a1d85b31de3d1d550d2a51f993 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 10 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000525742600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0742-3071 1464-5491 |
| IngestDate | Tue Nov 04 01:57:29 EST 2025 Sun Nov 09 11:24:37 EST 2025 Sat Nov 29 14:23:52 EST 2025 Wed Feb 19 02:31:34 EST 2025 Sat Nov 29 02:08:04 EST 2025 Tue Nov 18 22:39:05 EST 2025 Wed Jan 22 16:33:55 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Language | English |
| License | Attribution-NonCommercial 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4437-a64411da5e94e4f8acfc65a8256dbbf987ef8a5a1d85b31de3d1d550d2a51f993 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-7555-5348 0000-0003-2102-5461 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdme.14237 |
| PMID | 31967344 |
| PQID | 2424634926 |
| PQPubID | 1006515 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7496988 proquest_miscellaneous_2343500581 proquest_journals_2424634926 pubmed_primary_31967344 crossref_citationtrail_10_1111_dme_14237 crossref_primary_10_1111_dme_14237 wiley_primary_10_1111_dme_14237_DME14237 |
| PublicationCentury | 2000 |
| PublicationDate | August 2020 |
| PublicationDateYYYYMMDD | 2020-08-01 |
| PublicationDate_xml | – month: 08 year: 2020 text: August 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London – name: Hoboken |
| PublicationTitle | Diabetic medicine |
| PublicationTitleAlternate | Diabet Med |
| PublicationYear | 2020 |
| Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
| References | 2006; 92 2001; 91 2010; 55 2009; 47 2009; 69 2011; 2 2016; 19 2013; 127 2006; 59 2002; 359 2009; 374 1998; 316 2014; 371 2011; 34 2003; 18 2008; 31 2008; 2008 2005; 67 2011; 175 2007; 16 2016; 5 2012; 2 1980; 3 2011; 20 1997; 38 2005; 2 2009; 3 2001; 33 2011; 49 2016; 174 ADVANCE Collaborative Group (e_1_2_8_17_1) 2008; 2008 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_12_1 e_1_2_8_30_1 |
| References_xml | – volume: 127 start-page: 2233 year: 2013 end-page: 2249 article-title: Cardiovascular health: the importance of measuring patient‐reported health status publication-title: Circulation – volume: 47 start-page: 61 year: 2009 end-page: 68 article-title: Using the EQ‐5D index score as a predictor of outcomes in patients with type 2 diabetes publication-title: Med Care – volume: 59 start-page: 465 year: 2006 end-page: 471 article-title: Self‐rated health showed a graded association with frequently used biomarkers in a large population sample publication-title: J Clin Epidemiol – volume: 2008 start-page: 2560 year: 2008 end-page: 2572 article-title: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med – volume: 175 start-page: 228 year: 2011 end-page: 235 article-title: Self‐rated health compared with objectively measured health status as a tool for mortality risk screening in older adults: 10‐year follow‐up of the Bambui Cohort Study of Aging publication-title: Am J Epidemiol – volume: 19 start-page: 36 year: 2016 end-page: 41 article-title: Changes in quality of life associated with complications of diabetes: results from the ADVANCE study publication-title: Value Health – volume: 16 start-page: 163 year: 2007 end-page: 178 article-title: True health vs response styles: exploring cross‐country differences in self‐reported health publication-title: Health Econ – volume: 55 start-page: 340 year: 2010 end-page: 347 article-title: Importance of blood pressure lowering in type 2 diabetes: focus on ADVANCE publication-title: J Cardiovasc Pharmacol – volume: 18 start-page: 770 year: 2003 end-page: 779 article-title: Social participation and health in a community rich in stock of social capital publication-title: Health Educ Res – volume: 316 start-page: 736 year: 1998 end-page: 741 article-title: Variations in population health status: results from a United Kingdom national questionnaire survey publication-title: BMJ – volume: 38 start-page: 21 year: 1997 end-page: 37 article-title: Self‐rated health and mortality: a review of twenty‐seven community studies publication-title: J Health Social Behav – volume: 374 start-page: 369 year: 2009 end-page: 370 article-title: Use of patient‐reported outcomes in clinical practice publication-title: The Lancet. – volume: 33 start-page: 337 year: 2001 end-page: 343 article-title: EQ‐SD: a measure of health status from the EuroQol Group publication-title: Ann Med – volume: 31 start-page: 795 year: 2008 end-page: 797 article-title: Can self‐rated health scores be used for risk prediction in patients with type 2 diabetes? publication-title: Diabetes Care – volume: 359 start-page: 187 year: 2002 end-page: 188 article-title: Understanding self‐rated health publication-title: Lancet – volume: 2 start-page: 149 year: 2005 end-page: 158 article-title: Self‐rated health among older adults: a cross‐national comparison publication-title: Eur J Ageing – volume: 2 year: 2012 article-title: Self‐rated health and mortality in individuals with diabetes mellitus: prospective cohort study publication-title: BMJ Open – volume: 174 start-page: 103 year: 2016 end-page: 110 article-title: Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial publication-title: Am Heart J – volume: 67 start-page: 855 year: 2005 end-page: 861 article-title: Does subjective social status predict health and change in health status better than objective status? publication-title: Psychosom Med – volume: 20 start-page: 309 year: 2011 end-page: 320 article-title: Population health status in China: EQ‐5D results, by age, sex and socio‐economic status, from the National Health Services Survey 2008 publication-title: Qual Life Res – volume: 49 start-page: 962 year: 2011 end-page: 970 article-title: Comparability of patient‐reported health status: multicountry analysis of EQ‐5D responses in patients with type 2 diabetes publication-title: Med Care – volume: 371 start-page: 1392 year: 2014 end-page: 1406 article-title: Follow‐up of blood‐pressure lowering and glucose control in type 2 diabetes publication-title: N Engl J Med – volume: 34 start-page: 2491 year: 2011 end-page: 2495 article-title: Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? publication-title: Diabetes Care – volume: 69 start-page: 307 year: 2009 end-page: 316 article-title: What is self‐rated health and why does it predict mortality? Towards a unified conceptual model publication-title: Soc Sci Med – volume: 3 start-page: 37 year: 2009 end-page: 42 article-title: Are health‐related quality‐of‐life and self‐rated health associated with mortality? Insights from Translating Research Into Action for Diabetes (TRIAD) publication-title: Prim Care Diabetes – volume: 92 start-page: 1396 year: 2006 end-page: 1401 article-title: Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study publication-title: Heart – volume: 5 year: 2016 article-title: Participant‐Reported Health Status Predicts Cardiovascular and All‐Cause Mortality Independent of Established and Nontraditional Biomarkers: Evidence From a Representative US Sample publication-title: J Am Heart Assoc – volume: 2 start-page: 137 year: 2011 article-title: Patient‐reported outcomes: a new era in clinical research publication-title: Perspect Clin Res – volume: 3 start-page: 599 year: 1980 end-page: 606 article-title: The importance of self‐assessed health in patients with diabetes publication-title: Diabetes Care – volume: 91 start-page: 99 year: 2001 end-page: 104 article-title: Socioeconomic inequality in voting participation and self‐rated health publication-title: Am J Public Health – ident: e_1_2_8_9_1 doi: 10.1016/j.pcd.2009.01.001 – volume: 2008 start-page: 2560 year: 2008 ident: e_1_2_8_17_1 article-title: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med – ident: e_1_2_8_25_1 doi: 10.1136/bmj.316.7133.736 – ident: e_1_2_8_20_1 doi: 10.2337/dc11-0755 – ident: e_1_2_8_4_1 doi: 10.1016/j.jclinepi.2005.12.004 – ident: e_1_2_8_22_1 doi: 10.4103/2229-3485.86879 – ident: e_1_2_8_23_1 doi: 10.1016/S0140-6736(09)61400-8 – ident: e_1_2_8_6_1 doi: 10.1136/hrt.2005.085381 – ident: e_1_2_8_27_1 doi: 10.2337/diacare.3.5.599 – ident: e_1_2_8_5_1 doi: 10.1093/aje/kwr290 – ident: e_1_2_8_28_1 doi: 10.1097/FJC.0b013e3181d26469 – ident: e_1_2_8_31_1 doi: 10.1093/her/cyf044 – ident: e_1_2_8_15_1 doi: 10.1002/hec.1134 – ident: e_1_2_8_18_1 doi: 10.1056/NEJMoa1407963 – ident: e_1_2_8_8_1 doi: 10.1161/CIR.0b013e3182949a2e – ident: e_1_2_8_3_1 doi: 10.1161/JAHA.116.003741 – ident: e_1_2_8_26_1 doi: 10.1016/j.socscimed.2009.05.013 – ident: e_1_2_8_10_1 doi: 10.1136/bmjopen-2011-000760 – ident: e_1_2_8_21_1 doi: 10.1097/MLR.0b013e3181844855 – ident: e_1_2_8_2_1 doi: 10.2307/2955359 – ident: e_1_2_8_7_1 doi: 10.1016/S0140-6736(02)07466-4 – ident: e_1_2_8_13_1 doi: 10.1016/j.ahj.2015.12.009 – ident: e_1_2_8_29_1 doi: 10.2105/AJPH.91.1.99 – ident: e_1_2_8_14_1 doi: 10.1007/s10433-005-0032-7 – ident: e_1_2_8_24_1 doi: 10.1007/s11136-010-9762-x – ident: e_1_2_8_30_1 doi: 10.1097/01.psy.0000188434.52941.a0 – ident: e_1_2_8_19_1 doi: 10.3109/07853890109002087 – ident: e_1_2_8_16_1 doi: 10.1097/MLR.0b013e3182239489 – ident: e_1_2_8_11_1 doi: 10.2337/dc07-1391 – ident: e_1_2_8_12_1 doi: 10.1016/j.jval.2015.10.010 |
| SSID | ssj0012939 |
| Score | 2.3695033 |
| Snippet | Aims
To explore whether there is a different strength of association between self‐rated health and all‐cause mortality in people with type 2 diabetes across... Self‐rated health is an independent predictor of mortality in people with diabetes. The visual analogue scale (VAS) score has a stronger association with... To explore whether there is a different strength of association between self-rated health and all-cause mortality in people with type 2 diabetes across three... AimsTo explore whether there is a different strength of association between self‐rated health and all‐cause mortality in people with type 2 diabetes across... Self‐rated health is an independent predictor of mortality in people with diabetes.The visual analogue scale (VAS) score has a stronger association with... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1379 |
| SubjectTerms | Clinical trials Diabetes Diabetes mellitus (non-insulin dependent) Market economies Mortality Research: Epidemiology Risk factors |
| Title | Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdme.14237 https://www.ncbi.nlm.nih.gov/pubmed/31967344 https://www.proquest.com/docview/2424634926 https://www.proquest.com/docview/2343500581 https://pubmed.ncbi.nlm.nih.gov/PMC7496988 |
| Volume | 37 |
| WOSCitedRecordID | wos000525742600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1464-5491 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012939 issn: 0742-3071 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VFhAXHuW1UKoBceASaZM4sQMnRLviQJcKqLS3yK-IStu02qRI3PgJ_Bp-EL-EGedBVwUJicvKWo8V73omnhl7vg_guc-sL7TxkXYmowDFqEhVZhpRKCISUVnjtQpkE3I-V4tFcbgBr4ZamA4fYky4sWWE9zUbuDbNBSN3J57MPEnlFdiK41SySificDxCoH2s6DA4E06wxD2sEF_jGYeub0aXPMzLFyUvOrBhB5rd-q-534abveOJrztNuQMbvt6G6wf90fo2XOvzBnfhx0e_rH5--84gEg67QklsGO6ywbMVD2jxJHjt5MFjYCvC7iI6clYXOauLCQ5ZXRw4WNolSYc_AlvSIP-7AwNjxeorhhoTzt2_xHCYTi3kAhga4JF2UGbSQV27oU2zfD_HwDzS3IOj2f6nN2-jnt4hskKkMtLsisVOZ74QXlRK28rmmaaQNXfGVIWSnr7MdOxUZtLY-dTFjgIql-gsrsivug-b9WntHwIqq6dZZo1JZCWs1EoVYip87nViVWbzCbwY1rm0PfY5U3AsyyEGohUpw4pM4NkoetYBfvxJaGdQlrK3-abkQpucwR7pcU_HbrJWPoLRtT89J5mU3FOmcown8KDTrfEp_DKUqRATkGtaNwowEvh6T338OSCCS1HkhVL0M4PW_X3i5d7Bfmg8-nfRx3Aj4SRDuPW4A5vt6tw_gav2S3vcrHaD0dGnXKhd2Nr7MDt69ws9lDgZ |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB6VLX8XfgotCwUGxKGXSJvEThzEBdGuithdELRSb5FjO6LSNq12UyRuPAJPwwPxJMw4P3RVkJC4Weux4qxn4pmx5_sAXjhpXKYLF2hbSApQChWoshgFFIqISJSmcFp5sol0NlNHR9mHNXjV1cI0-BB9wo0tw3-v2cA5IX3Byu2JIzuP4vQKrAtSIzmA9d2P48NJf4pAW1nWwHBGnGMJW2QhvsnTD17djy45mZfvSl70Yf0mNL79f9O_A7da5xNfN9pyF9ZctQHXp-3x-gZca3MH9-DHJzcvf377zkASFptiSVwy5OUSzxY8oMYT77mTF4-esQiby-jImV3kzC5G2GV2seNhqeck7f8JrEmL3O8O9KwVi6_o60w4f_8S_YE6tZCLYGiAQ9pFmU0HdWW7Ns3y_Qw9-8jyPhyO9w7e7ActxUNghIjTQLM7FlotXSacKJU2pUmkprA1sUVRZip19KPUoVWyiEPrYhtaCqpspGVYkm-1CYPqtHIPAJXRIylNUURpKUyqlcrESLjE6cgoaZIh7HQLnZsW_5xpOOZ5FwfRiuR-RYbwvBc9a0A__iS03WlL3tr9Mudim4QBH-lxz_puslg-htGVOz0nmZhcVKZzDIew1ShX_xT-IKaxEENIV9SuF2A08NWe6vizRwVPRZZkStFrerX7-8Tz3emebzz8d9GncGP_YDrJJ29n7x7BzYiTDv4W5DYM6sW5ewxXzZf6eLl40trgLxR8Ow4 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VAlUvPMqjCwUGxIFLpE1iJw7igmhXIOiyEiD1FvkVUWmbrnZTJG78BH4NP4hfwozzoKuChMTNiseKE8_YM-OZbwCeeml9oY2PtDOSDBSjIlWZcUSmiEhEZY3XKhSbyKdTdXRUzDbgRZ8L0-JDDA43loywX7OA-4Wrzkm5O_Ek50maX4LLQtIey7jOYjbcIdBBVrQgnAl7WOIOV4jjeIah66fRBRXzYqTkeQ02HEGT6_83-RtwrVM98WXLKzdhw9c7sHXYXa7vwNXOc3ALfnzw8-rnt-8MI-GwTZXEFQNernCx5AENngS9nXR4DPWKsA1FR_brIvt1McHer4t9FZZmTtThT2BDPOR_d2CoWbH8iiHLhL33zzFcp1MLOQWGBnikM5Rr6aCuXd-mWb6fYqg9sroNnyYHH1-9jroCD5EVIs0jzcpY7LT0hfCiUtpWNpOajNbMGVMVKvf0UOrYKWnS2PnUxY5MKpdoGVekWd2Bzfq09ruAyuqxlNaYJK-EzbVShRgLn3mdWCVtNoJn_UKXtkM_5yIc87K3gmhFyrAiI3gykC5ayI8_Ee313FJ2Ur8qOdUmY7hHet3joZvklS9hdO1Pz4gmJQWViznGI7jbMtfwFt4O81SIEeRrbDcQMBb4ek99_DlggueiyAql6DMD2_194uX-4UFo3Pt30kewNduflO_eTN_eh-2EPQ4hBHIPNpvlmX8AV-yX5ni1fBgE8BfO8Dj3 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Self%E2%80%90rated+health+scores+predict+mortality+among+people+with+type+2+diabetes+differently+across+three+different+country+groupings%3A+findings+from+the+ADVANCE+and+ADVANCE%E2%80%90ON+trials&rft.jtitle=Diabetic+medicine&rft.au=Hua%2C+X.&rft.au=Lung%2C+T.+W.+C.&rft.au=Woodward%2C+M.&rft.au=Salomon%2C+J.+A.&rft.date=2020-08-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=0742-3071&rft.eissn=1464-5491&rft.volume=37&rft.issue=8&rft.spage=1379&rft.epage=1385&rft_id=info:doi/10.1111%2Fdme.14237&rft_id=info%3Apmid%2F31967344&rft.externalDocID=PMC7496988 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3071&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3071&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3071&client=summon |